Page last updated: 2024-10-27

fenofibrate and Chagas Cardiomyopathy

fenofibrate has been researched along with Chagas Cardiomyopathy in 3 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Chagas Cardiomyopathy: A disease of the CARDIAC MUSCLE developed subsequent to the initial protozoan infection by TRYPANOSOMA CRUZI. After infection, less than 10% develop acute illness such as MYOCARDITIS (mostly in children). The disease then enters a latent phase without clinical symptoms until about 20 years later. Myocardial symptoms of advanced CHAGAS DISEASE include conduction defects (HEART BLOCK) and CARDIOMEGALY.

Research Excerpts

ExcerptRelevanceReference
"Fenofibrate treatment restored to normal values the ejection and shortening fractions, left ventricular end-diastolic, left ventricular end-systolic diameter, and isovolumic relaxation time."5.46Treatment with Fenofibrate plus a low dose of Benznidazole attenuates cardiac dysfunction in experimental Chagas disease. ( Cevey, ÁC; Donato, M; Gelpi, RJ; Goren, NB; Mirkin, GA; Penas, FN; Rada, MJ, 2017)
"Fenofibrate treatment restored to normal values the ejection and shortening fractions, left ventricular end-diastolic, left ventricular end-systolic diameter, and isovolumic relaxation time."1.46Treatment with Fenofibrate plus a low dose of Benznidazole attenuates cardiac dysfunction in experimental Chagas disease. ( Cevey, ÁC; Donato, M; Gelpi, RJ; Goren, NB; Mirkin, GA; Penas, FN; Rada, MJ, 2017)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Cevey, ÁC3
Pieralisi, AV2
Donato, M3
Rada, J2
Gelpi, RJ2
Mirkin, GA3
Goren, NB3
Penas, FN3
Alba Soto, C1
Gelpi, R1
Rada, MJ1

Other Studies

3 other studies available for fenofibrate and Chagas Cardiomyopathy

ArticleYear
Macrophages Mediate Healing Properties of Fenofibrate in Experimental Chagasic Cardiomyopathy.
    ACS infectious diseases, 2023, 02-10, Volume: 9, Issue:2

    Topics: Cardiomyopathies; Chagas Cardiomyopathy; Chagas Disease; Fenofibrate; Humans; Macrophages

2023
IL-10-Dependent and -Independent Mechanisms Are Involved in the Cardiac Pathology Modulation Mediated by Fenofibrate in an Experimental Model of Chagas Heart Disease.
    Frontiers in immunology, 2020, Volume: 11

    Topics: Animals; Cells, Cultured; Chagas Cardiomyopathy; Creatine Kinase; Disease Models, Animal; Fenofibrat

2020
Treatment with Fenofibrate plus a low dose of Benznidazole attenuates cardiac dysfunction in experimental Chagas disease.
    International journal for parasitology. Drugs and drug resistance, 2017, Volume: 7, Issue:3

    Topics: Animals; Chagas Cardiomyopathy; Chagas Disease; Diastole; Fenofibrate; Fibrosis; Humans; Inflammatio

2017